Signal transduction from multiple Ras effectors

Current Opinion in Genetics and Development

Volumn 7, Issue 1, 1997, Pages 75-79

  Katz, Michael E ^a   McCormick, Frank ^b  

^a BAYER CORPORATION   (United States)

^b ONYX PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; PHOSPHATIDYLINOSITOL KINASE; PROTEIN SERINE THREONINE KINASE; RAF PROTEIN; RAS PROTEIN;

ARTICLE; BIOCHEMISTRY; HUMAN; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0031043776     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(97)80112-8     Document Type: Article

References (50)

1. Polakis P, McCormick F. Structural requirements for the interaction of p21ras with GAP, exchange factors, and its biological effector target. J Biol Chem. 268:1993;9157-9160.
2. Moodie SA, Paris M, Villafranca E, Kirshmeier P, Willumsen BM, Wolfman A. Different structural requirements within the switch II region of the Ras protein for interaction with specific downstream targets. Oncogene. 11:1995;447-454.
3. Hwang M-CC, Sung Y-J, Hwang Y-W. The differential effects of the gly-60 to ala mutation on the interaction H-Ras p21 with different downstream targets. J Biol Chem. 271:1996;8196-8202.
4. Marshall MS. The effector interactions of p21ras. Trends Biochem Sci. 18:1993;250-254.
5. Fujita-Yoshigaki J, Shirouzu M, Ito Y, Hattori S, Furuyama S, Nishimura S, Yokoyama S. A constitutive effector region on the C-terminal side of switch I of the Ras protein. J Biol Chem. 270:1995;4661-4667.
6. Gibbs JB, Marshall MS. The ras oncogene - an important regulatory element in lower eukaryotic organisms. Microbiol Rev. 53:1989;171-185.
7. Pazin MJ, Williams LT. Triggering signaling cascades by receptor tyrosine kinases. Trends Biochem Sci. 17:1992;374-378.
8. Avruch J, Zhang X-f, Kyriakis JM. Raf meets ras: completing the framework of a signal transduction pathway. Trends Biochem Sci. 19:1994;279-283.
9. Marshall M. Ras target proteins in eukaryotic cells. FASEB J. 9:1995;1311-1318.
10. McCormick F. Ras-related proteins in signal transduction and growth control. Mol Reproduc Dev. 42:1995;500-506.
11. Song KS, Li S, Okamoto T, Quilliam LA, Sargiacomo M, Lisanti MP. Co-purificaiton and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. J Biol Chem. 271:1996;9690-9697.
12. Mineo C, James GL, Smart EJ, Anderson RGW. Localization of epidermal growth factor-stimulated Ras/Raf-1 interaction to caveolae membrane. J Biol Chem. 271:1996;11930-11935.
13. Hill CS, Treisman R. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell. 80:1995;199-211.
14. Yamamori B, Kuroda S, Shimizu K, Fukui K, Ohtsuka T, Takai Y. Purification of a Ras-dependent mitogen-activated protein kinase kinase kinase from bovine brain cytosol and its identification as a complex of B-Raf and 14-3-3 proteins. of special interest J Biol Chem. 270:1995;11723-11726 Ras could not be shown to activate c-Raf-1 in vitro, suggesting that Ras simply acted as a shuttle vehicle for moving Raf to the plasma membrane where it could be activated by other mechanisms. These authors, however, demonstrated that Ras could do far more by showing that GTP-Ras directly activated B-Raf in a pure cell-free system.
15. D'Arcangelo G, Halegoua S. A branched signaling pathway for nerve growth factor is revealed by src-, ras-, and raf-mediated gene inductions. Mol Cell Biol. 13:1993;3146-3155.
16. Thorburn J, Frost JA, Thornburn A. Mitogen-activated protein kinases mediate changes in gene expression, but not cytoskeletal organization associated with cardiac muscle cell hypertrophy. Cell Biol. 126:1994;1565-1572.
17. Bar-Sagi D, Feramisco JR. Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins. Science. 233:1986;1061-1068.
18. Ridley AJ. Membrane ruffling and signal transduction. Bioessays. 16:1994;321-327.
19. Joneson T, White MA, Wigler MH, Bar-Sagi D. Stimulation of membrane ruffling and MAP kinase activation by distinct effectors of RAS. of special interest Science. 271:1996;810-812 By expressing effector loop mutants of V12 Ras in cells, these authors demonstrated that Ras is a common upstream element of at least two distinct signaling pathways. One is the classic MAPK pathway and the other is pathway that regulates the actin cytoskeleton; both appear to be required for the optimal mitogenic signal from activated Ras. (This work is an application of an approach pioneered by Michael White and Mike Wigler.).
20. Symons M. Rho family GTPases: the cytoskeleton and beyond. Trends Biochem Sci. 21:1996;178-181.
21. Boguski MS, McCormick F. Proteins regulating Ras and its relatives. Nature. 366:1993;643-654.
22. Lange-Carter CA, Johson GL. Ras-dependent growth factor regulation of MEK kinase in PC12 cells. Science. 265:1994;1458-1461.
23. Russell M, Lange C, Johnson GL. Direct interaction between Ras and the kinase domain of mitogen-activated protein kinase kinase kinase (MEKK1). J Biol Chem. 270:1995;11757-11760.
24. Diaz-Meco MT, Lozano J, Municio MM, Berra E, Frutos S, Sanz L, Moscat J. Evidence for the in vitro and in vivo interaction of Ras with protein kinase Cξ J Biol Chem. 269:1994;31706-31710.
25. Berra E, Diameco MT, Lozano J, Frutos S, Municio MM, Sanchez P, Sanz L, Moscat J. Evidence for a role of MEK and MAPK during signal-transduction by protein kinase Cξ EMBO J. 14:1995;6157-6163.
26. Kuriyama M, Harada N, Kuroda S, Yamamoto T, Nakafuku M, Iwamatsu A, Yamamoto D, Prasad R, Croce C, Canaani E, et al. Identification of AF-6 and Canoe as putative targets for Ras. J Biol Chem. 271:1996;607-610.
27. Prasad R, Gu Y, Alder H, Nakamura T, Canaani O, Saito H, Huebner K, Gale RP, Nowell P, Kuriyama K, et al. Cloning of the ALL-1 fusion partner, the AF-6 gene, involved in acute myeloid leukemias with the t(6;11) chromosome translocation. Cancer Res. 53:1993;5624-5628.
28. Han LM, Colicelli J. A human protein selected for interference with Ras functions interacts directly with Ras and competes with Raf. of special interest Mol Cell Biol. 15:1995;1318-1323 This is a validation of earlier work from Colicelli using suppression of Ras function in yeast by expressed human cDNAs as a screen for proteins that bind to activated Ras at the effector site. The authors also point out the conserved nature of the Ras pathway among eukaryotes and how this can be exploited to identify novel effectors.
29. Kornfeld K, Db H, Horvitz HR. The ksr-1 gene encodes a novel protein kinase involved in ras-mediated signaling in C. elegans. Cell. 83:1995;903-913.
30. Sundaram M, Han M. The C. elegans ksr-1 gene encodes a novel raf-related kinase involved in ras-mediated signal transduction. Cell. 83:1995;889-901.
31. Therrien M, Chang HC, Solomon NM, Karim FD, Wassarman DA, Rubin GM. KSR, a novel protein kinase required for RAS signal transduction. Cell. 83:1995;879-888.
32. Albright CF, Giddings BW, Liu J, Vito M, Weinberg RA. Characterization of a guanine nucleotide dissociation stimulator for a ras-related GTPase. EMBO J. 12:1993;339-347.
33. Holer F, Fields S, Schneider C, Martin GS. Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. Proc Natl Acad Sci USA. 91:1994;11089-11093.
34. Kikuchi A, Demo SD, Ye Z-H, Chen YW, Williams LT. ralGDS family members interact with the effector domain of ras p21. Mol Cell Biol. 14:1994;7483-7491.
35. Spaargaren M, Bischoff JR. Identification of the guanine nucleotide dissociation stimulator for Ral as a putative effector molecule of R-ras, H-ras, and Rap. Proc Natl Acad Sci USA. 91:1994;12609-12613.
36. Kikuchi A, Williams LT. Regulation of interaction of ras p21 with RalGDS and Raf-1 by cyclic AMP-dependent protein kinase. J Biol Chem. 271:1996;588-594.
37. Urano T, Emkey R, Feig LA. Ral-GTPases mediate a distinct downstream signaling pathway from ras that facilitates transformation. EMBO J. 15:1996;810-816.
38. White MA, Vale T, Camonis JH, Schaefer E, Wigler MH. A role for the ral guanine nucleotide dissociation stimulator in mediating ras-induced transformation. J Biol Chem. 271:1996;16439-16442.
39. Wolthius RMF, Bauer B, Van't Veer LJ, De Vries-Smits AMM, Cool RH, Spaargaren M, Wittinghofer A, Burgering BMT, Bos JL. RalGDS-like factor (Rlf) is a novel Ras and Rap 1A-associating protein. Oncogene. 13:1996;353-362.
40. Kapeller R, Cantley LC. Phosphatidylinositol 3-kinase. Bioessays. 16:1994;565-576.
41. Rodriguez-Viciana P, Warne PH, Dhand R, Vanhaesbroeck B, Gout I, Fry MJ, Waterfield MD, Downward J. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature. 370:1994;527-532.
42. Rodriguez-Viciana P, Warne PH, Waterfield MD, Downward J. Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation. EMBO J. 15:1996;2242-2251.
43. Hawkins PT, Eguinoa A, Qiu R-G, Stokoe D, Cooke FT, Walters R, Wennström S, Claesoon-Welsh L, Evans T, Symons M, Stephens L. PDGF stimulates an increase in GTP-Rac via activation of phosphoinositide 3-kinase. Curr Biol. 5:1995;393-403.
44. White MA, Nicolette C, Minden A, Polverino A, Van Aelst L, Karin M, Wigler MH. Multiple ras functions can contribute to mammalian cell transformation. of outstanding interest Cell. 80:1995;533-541 Brilliant demonstration of the power of effector mutants to dissect Ras signaling pathways. This approach has been invaluable for the Ras field and is now being applied equally successfully to dissection of multiple Rac signaling pathways.
45. Khosravi-Far R, White MA, Westwick JK, Solski PA, Chrzanowska-Wodnicka M, Van Aelst L, Wigler MH, Der CJ. Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation. Mol Cell Biol. 16:1996;3923-3933.
46. Hughes DA. Control of signal transduction and morphogenesis by ras. Semin Cell Biol. 6:1995;89-94.
47. Akaska K, Tamada M, Wang F, Kariya K-I, Shima F, Kikuchi A, Yamamoto M, Shirouzo M, Yokoyama S, Kataoka T. Differential structural requirements for interaction of Ras protein with its distinct downstream effectors. J Biol Chem. 271:1996;5335-5360.
48. Boudewijn M, Burgering T, Bos J. Regulation of Ras-mediated signaling: more than one way to skin a cat. Trends Biochem Sci. 20:1995;18-23.
49. Wooten MW, Seibenhener ML, Matthews LH, Zhou GS, Coleman ES. Modulation of ξ-protein kinase-C by cyclic-AMP in PC12 cells occurs through phosphorylation by protein kinase-A. J Neurochem. 67:1996;1023-1031.
50. Cook SJ, Rubinfeld B, Albert I, McCormick F. RapV12 antagonizes ras-dependent activation of ERK-1 and ERK-2 by LPA and EGF in Rat-1 fibroblasts. EMBO J. 12:1993;3475-3485.